Skip to content Skip to navigation

Millennium Laboratories acquires RxAnte

January 14, 2014
by Shannon Brys, Associate Editor
| Reprints

Millennium Laboratories, an organization that works with the science of medication monitoring and pharmacogenetic testing, has announced its acquisition of RxAnte, a healthcare predictive analytics and decision support company that improves population-level medication adherence on behalf of health plans, pharmacy benefit management companies, pharmacy chains, and healthcare providers.

The acquisition will link two fast-growing healthcare technology companies that share a strong commitment to improving the safe and effective use of prescription medications through personalized, technology-enabled drug therapy management solutions.

Millennium currently offers medication monitoring using urine drug testing (UDT) and pharmacogenetic testing (PGT) to health professionals treating, pain, substance use disorders, psychiatric disorders, and other chronic diseases. RxAnte is a venture-backed digital health care start-up launched in 2011 and based in the Washington, DC area.

RxAnte, whose predictive analytics and decision support platform now manages the medication adherence of over 8 million unique patients, will operate as a wholly owned subsidiary of Millennium. The company's suite of products for payers and healthcare providers identifies patients at risk of avoidable costs due to improper medication use or non-adherence and then recommends specific steps for practitioners, pharmacists, and other members of the care team to support at-risk patients.

"Improving medication adherence is increasingly recognized as one of the biggest opportunities to improve patient outcomes and quality of care while slowing the growth of healthcare costs," said Millennium's CEO, Brock Hardaway. "The acquisition of RxAnte represents an exciting step for Millennium in continuing to pursue its strategic vision to improve care quality and health outcomes."

Beyond continuing to grow their respective core businesses, Millennium and RxAnte also plan to collaborate on new products and services to help payers and health care providers further personalize drug therapy management, improve population health, and reduce the avoidable costs of medication misuse.

Topics

Comments

I would suggest that people interested in this story use their Google search engine to get information on Millennium Laboratories. After the obligatory first posting of the organizations webpage, you will note postings first from the Pathology Blawg, and second from Reuters. Both make very interesting reading.

Pages